Long-term efficacy, safety and durability of Juvederm (R) XC

被引:18
|
作者
Ballin, Annelyse C. [1 ]
Cazzaniga, Alex [1 ]
Brandt, Fredric S. [1 ]
机构
[1] Dermatol Res Inst, Miami, FL USA
关键词
dermal filler; hyaluronic acid; Juvederm XC; lidocaine; Juvederm; dermatologic procedures;
D O I
10.2147/CCID.S33568
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Over the last decade, there has been increasing interest in minimally invasive cosmetic treatments, especially for facial rejuvenation. Next to botulinum toxin injection, the injection of soft tissue fillers is the second most frequent minimally invasive procedure performed in the USA. Hyaluronic acid (HA) is the most commonly used dermal filler. One of patients' main concerns about filler injections pertains to pain and discomfort. Topical anesthetics, nerve blocks, and/or the incorporation of lidocaine to the filler have been applied in order to reduce distress and pain. Despite nerve blocks being an effective form of anesthesia, they may distort the area to be treated, as well as lengthen and complicate the procedure. Studies have shown that the incorporation of lidocaine to HA fillers significantly reduces pain and discomfort. Yet, one of the dilemmas about the addition of lidocaine solution to HA fillers is the possible alteration of the physical characteristics of the product by negatively impacting the efficacy and/or duration of the filler. The concern is that the addition of lidocaine could dilute the product, creating less correction per mL, changing the product's viscosity and consequently the "lifting" ability. Also, this dilution could reduce the product's duration. There may be a difference between a physician adding an aqueous solution into a lidocaine-free version of HA and the pre-incorporated lidocaine version of HA. An aqueous solution might dilute the product, while the pre-incorporated powder lidocaine appears to avoid this problem. Juvederm((R)) XC is manufactured with powder lidocaine 0.3%; it is associated with significantly less injection pain than Juvederm((R)) and other lidocaine-free versions of HA. Studies have shown that lidocaine enhances treatment comfort and optimizes the injection experience while maintaining a similar safety and effectiveness profile. Regarding the longevity, further study is necessary to determine if there is any difference in durability.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 50 条
  • [31] Long-term Efficacy and Safety of Immunosuppression for the Uveitides
    Jabs, Douglas A.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 58 - 59
  • [32] Efficacy and safety of long-term risperidone treatment
    Hotujac, LJ
    Sagud, M
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 (04) : 193 - 197
  • [33] SAFETY AND EFFICACY OF LONG-TERM DIAZEPAM THERAPY
    BOWDEN, CL
    FISHER, JG
    SOUTHERN MEDICAL JOURNAL, 1980, 73 (12) : 1581 - 1584
  • [34] Secukinumab: Long-term Safety and Efficacy in Psoriasis
    Hashim, Peter W.
    Lebwohl, Mark G.
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (08) : S115 - S117
  • [35] Long-term efficacy and safety of iloperidone: an update
    Rado, Jeffrey T.
    Janicak, Philip G.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 409 - 415
  • [36] LONG-TERM ASSESSMENT OF DRUG SAFETY AND EFFICACY
    TURNER, P
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1984, 77 (02) : 93 - 94
  • [37] SAFETY AND EFFICACY OF LONG-TERM DISOPYRAMIDE PHOSPHATE
    BAUMAN, J
    BAUERNFEIND, R
    SWIRYN, S
    STRASBERG, B
    PALILEO, E
    HOFF, J
    ROSEN, K
    AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (04): : 1003 - 1003
  • [38] Safety and Efficacy of Long-Term Disulfiram Aftercare
    Mutschler, Jochen
    Dirican, Guelseren
    Gutzeit, Andreas
    Grosshans, Martin
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (05) : 195 - 198
  • [39] EFFICACY, SAFETY AND LONG-TERM DURABILITY OF ENDOVASCULAR TREATMENT OF MCA ANEURYMS: A REVIEW OF 161 TREATED ANEURYSMS
    Hannan, C.
    Sunderland, G.
    Zakaria, R.
    Niven, S.
    Nahser, H.
    Putharan, M.
    Chandran, A.
    Javadpour, M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (03): : E52 - E52
  • [40] LONG-TERM DURABILITY OF GEOMEMBRANES
    KOERNER, RM
    HALSEHSUAN, Y
    LORD, AE
    CIVIL ENGINEERING, 1991, 61 (04): : 56 - 58